These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 8305235

  • 1. Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.
    Vangsted AJ, Zeuthen J.
    Acta Oncol; 1993; 32(7-8):845-51. PubMed ID: 8305235
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. New serum markers for small-cell lung cancer. I. The ganglioside fucosyl-GM1.
    Vangsted A, Drivsholm L, Andersen E, Pallesen T, Zeuthen J, Wallin H.
    Cancer Detect Prev; 1994; 18(3):221-9. PubMed ID: 8076384
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reactivity of monoclonal antibodies with ganglioside antigens in human small cell lung cancer tissues.
    Brezicka T, Bergman B, Olling S, Fredman P.
    Lung Cancer; 2000 Apr; 28(1):29-36. PubMed ID: 10704706
    [Abstract] [Full Text] [Related]

  • 6. Fucosyl-GM1 in small-cell lung cancer. A comparison with the tumour marker neuron-specific enolase.
    Drivsholm L, Vangsted A, Pallesen T, Hansen M, Dombernowsky P, Hirsch F, Hansen HH.
    Ann Oncol; 1994 Sep; 5(7):623-6. PubMed ID: 7993838
    [Abstract] [Full Text] [Related]

  • 7. Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer.
    Brezicka FT, Olling S, Bergman B, Berggren H, Engström CP, Hammarström S, Holmgren J, Larsson S, Lindholm L.
    Tumour Biol; 1992 Sep; 13(5-6):308-15. PubMed ID: 1337798
    [Abstract] [Full Text] [Related]

  • 8. Selection of GM2, fucosyl GM1, globo H and polysialic acid as targets on small cell lung cancers for antibody mediated immunotherapy.
    Livingston PO, Hood C, Krug LM, Warren N, Kris MG, Brezicka T, Ragupathi G.
    Cancer Immunol Immunother; 2005 Oct; 54(10):1018-25. PubMed ID: 15926079
    [Abstract] [Full Text] [Related]

  • 9. A Novel, Fully Human Anti-fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer.
    Ponath P, Menezes D, Pan C, Chen B, Oyasu M, Strachan D, LeBlanc H, Sun H, Wang XT, Rangan VS, Deshpande S, Cristea S, Park KS, Sage J, Cardarelli PM.
    Clin Cancer Res; 2018 Oct 15; 24(20):5178-5189. PubMed ID: 30021910
    [Abstract] [Full Text] [Related]

  • 10. Detection of a ganglioside antigen associated with small cell lung carcinomas using monoclonal antibodies directed against fucosyl-GM1.
    Nilsson O, Brezicka FT, Holmgren J, Sörenson S, Svennerholm L, Yngvason F, Lindholm L.
    Cancer Res; 1986 Mar 15; 46(3):1403-7. PubMed ID: 3002616
    [Abstract] [Full Text] [Related]

  • 11. Small cell lung cancer is not associated with the presence of anti-fucosyl-GM1 ganglioside autoantibodies reactive in immunoenzymatic test.
    Adler G, Pacuszka T, Lewartowska A, Rowinska E, Oblakowski P, Panasiewicz M.
    Lung Cancer; 2001 Dec 15; 34(3):383-5. PubMed ID: 11714535
    [Abstract] [Full Text] [Related]

  • 12. Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin.
    Krug LM, Ragupathi G, Hood C, Kris MG, Miller VA, Allen JR, Keding SJ, Danishefsky SJ, Gomez J, Tyson L, Pizzo B, Baez V, Livingston PO.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6094-100. PubMed ID: 15447995
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-cell killing by MAbs against fucosyl GM1, a ganglioside antigen associated with small-cell lung carcinoma.
    Brezicka FT, Holmgren J, Kalies I, Lindholm L.
    Int J Cancer; 1991 Dec 02; 49(6):911-8. PubMed ID: 1660040
    [Abstract] [Full Text] [Related]

  • 15. Immunization of mice with fucosyl-GM1 conjugated with keyhole limpet hemocyanin results in antibodies against human small-cell lung cancer cells.
    Cappello S, Liu NX, Musselli C, Brezicka FT, Livingston PO, Ragupathi G.
    Cancer Immunol Immunother; 1999 Dec 02; 48(9):483-92. PubMed ID: 10602885
    [Abstract] [Full Text] [Related]

  • 16. Immunogenicity of a fucosyl-GM1-keyhole limpet hemocyanin conjugate vaccine in patients with small cell lung cancer.
    Dickler MN, Ragupathi G, Liu NX, Musselli C, Martino DJ, Miller VA, Kris MG, Brezicka FT, Livingston PO, Grant SC.
    Clin Cancer Res; 1999 Oct 02; 5(10):2773-9. PubMed ID: 10537341
    [Abstract] [Full Text] [Related]

  • 17. New serum markers for small-cell lung cancer. II. The neural cell adhesion molecule, NCAM.
    Vangsted A, Drivsholm L, Andersen E, Bock E.
    Cancer Detect Prev; 1994 Oct 02; 18(4):291-8. PubMed ID: 7982239
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic and therapeutic applications of monoclonal antibodies to small cell carcinoma of the lung.
    Okabe T, Takaku F.
    Jpn J Clin Oncol; 1986 Sep 02; 16(3):243-52. PubMed ID: 3022033
    [Abstract] [Full Text] [Related]

  • 19. Radiolocalization of human small cell lung cancer and antigen-positive normal tissues using monoclonal antibody LS2D617.
    Wilson BS, Petrella E, Lowe SR, Lien K, Mackensen DG, Gridley DS, Stickney DR.
    Cancer Res; 1990 May 15; 50(10):3124-30. PubMed ID: 2159374
    [Abstract] [Full Text] [Related]

  • 20. Anti-fucosyl-GM1 ganglioside IgG and IgM autoantibodies in human serum: no link to pathology.
    Adler G, Pacuszka T, Strugalska M, Targońska I, Panasiewicz M, Lewartowska A.
    Immunol Lett; 1996 Sep 15; 52(2-3):89-93. PubMed ID: 8905401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.